Rushed Amendments Could Have Unintended Consequences: C.D. Howe Institute Competition Policy Council
Rushed Amendments Could Have Unintended Consequences: C.D. Howe Institute Competition Policy Council
April 28, 2022 – The C.D. Howe Institute Competition Policy Council supports the Minister of Innovation, Science and Industry’s recent statement that “competition in the economy is the driving force behind innovation, efficiency and adaptability.”
However, in “Bring on the Competition: Reforming Canada’s Competition Act,” the Council’s 22nd report, it cautions that rushed amendments to the Competition Act without careful consideration and thoughtful debate could have unintended consequences for these forces in the Canadian economy. “Even perceived shortcomings in the Competition Act may not easily be addressed without unintended consequences,” according to the Council’s latest Communiqué.
…
C.D. Howe Institute Monetary Policy Council Calls for Bank of Canada to Raise Overnight Rate to 1.00 Percent Next Week and 2.25 Percent in a Year’s Time, and Shrink Bond Holdings
April 7, 2022 – The C.D. Howe Institute’s Monetary Policy Council (MPC) recommends that the Bank of Canada raise its target for the overnight rate, its benchmark policy interest rate, by 50 basis points to 1.00 percent on April 13th. The MPC recommends further increases over the coming year: to at least 1.25 percent in June, 2.00 by October, and 2.25 percent by April 2023. It also recommends that the Bank reduce its holdings of Government of Canada bonds between now and its May overnight-rate target announcement.
The MPC provides an independent assessment of the monetary stance consistent with the Bank of Canada’s 2 percent inflation target. William Robson, the Institute’s CEO, chairs the Council.
Council…
C.D. Howe Institute Monetary Policy Council Calls for Bank of Canada to Raise Overnight Rate to 0.50 Percent Next Week on Way to 1.75 Percent in a Year’s Time, and Shrink Bond Holdings
February 24, 2022 – The C.D. Howe Institute’s Monetary Policy Council (MPC) recommends that the Bank of Canada raise its target for the overnight rate, its benchmark policy interest rate, to 0.50 percent on March 2nd, with further increases to 0.75 percent in April, 1.25 percent by September, and 1.75 percent this time next year. It also recommends that the Bank reduce its holdings of Government of Canada bonds between now and its April overnight-rate target announcement.
The MPC provides an independent assessment of the monetary stance consistent with the Bank of Canada’s 2 percent inflation target. William Robson, the Institute’s CEO, chairs the Council. Council members make…
C.D. Howe Institute Monetary Policy Council Calls for Bank of Canada to Raise Overnight Rate, Shrink Bond Holdings
January 20, 2022 – The C.D. Howe Institute’s Monetary Policy Council (MPC) recommends that the Bank of Canada raise its target for the overnight rate, its benchmark policy interest rate, to 0.50 percent at its next announcement on January 26th. The Council recommended further increases over the coming year, with the target reaching 1.50 percent by January of 2023. It also recommends that the Bank reduce its holdings of Government of Canada bonds prior to its next overnight rate target announcement in March.
The MPC provides an independent assessment of the monetary stance consistent with the Bank of Canada’s 2 percent inflation target. William Robson, the Institute’s CEO, chairs the Council…
Pharmaceutical Supply Chain Sustainability
On September 29, 2021, the C.D. Howe Institute invited trusted experts in both the public and private sectors to participate in a Special Policy Seminar on the sustainability and resiliency of Canada’s pharmaceutical supply chains and other issues surrounding domestic manufacturing.
The general consensus among participants found that improving emergency preparedness, increasing domestic manufacturing capacity, and investment in the monitoring of drug supply inventories would all be beneficial for supply chain resiliency. Beyond this, the participants agreed there is a role for government to provide leadership, oversight, and investment in vaccine development and manufacturing, while also promoting public policy that contributes…
